Our Pipeline

DISCO develops a pipeline of first-in-class AND-gated T-cell engagers and Antibody-Drug Conjugates in Colorectal Cancer and Small Cell Lung Cancer, with additional tumor types currently in discovery phase.

Technology

Our pioneering surfaceome mapping platform expands the drug target universe, enabling the development of new AND-gated therapeutics that achieve higher therapeutic index through reduced off-tumor activity.

Our Team

A stellar team of individuals with diverse backgrounds from academia, biotech and pharma.